Global Anti-Nuclear Antibody Testing Market 2017-2021; New Report Launched

DrugPipeline.net has announced the addition of “Global Anti-nuclear Antibody (ANA) Testing Market 2017 - 2021” research report to their website www.DrugPipeline.net


Bangalore, India -- (SBWIRE) -- 06/12/2017 -- Antibodies that attack healthy proteins in the nucleus cells are called antinuclear antibodies. When a person has an autoimmune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE), the immune system produces antibodies that will attach to the cells, often causing damage to them. Some of the ANA tests are EUROPLUS ANA Mosaic 20A, QUANTA Lite ANA, BioPlex 2200 ANA Screen. The global ANA testing market is expected to benefit from the growing incidence of several autoimmune diseases worldwide.

Report forecast the global anti-nuclear antibody (ANA) testing market to grow at a CAGR of 7.13 % during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global anti-nuclear antibody (ANA) testing market for 2017-2021. To calculate the market size, the report considers the new installations/sales/volume/value and replacement/ services of anti-nuclear antibody testing market.

The market is divided into the following segments based on geography:
- Americas

Global Anti-Nuclear Antibody (ANA) Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Alere
- Bio-Rad Laboratories
- Thermo Fisher Scientific

Other prominent vendors
- Antibodies Incorporated
- Biocom Biotech
- Erba Diagnostics
- F. Hoffmann-La Roche
- HOB Diagnostics
- HUMAN Diagnostics
- ImmunArray
- Phadia
- Seramun Diagnostica
- Trinity Biotech

Market driver
- Increased prevalence of autoimmune diseases
- For a full, detailed list, view our report

Market challenge
- Limitations of autoimmune disease diagnostics
- For a full, detailed list, view our report

Market trend
- Shift from monoplex to multiplex testing
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages "Global Anti-nuclear Antibody (ANA) Testing Market 2017 - 2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Market segmentation by end-user, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-anti-nuclear-antibody-ana-testing-market-2017-2021

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.